Discover B2B leads for Pharmaceuticals industry
Identify and research relevant prospects for B2B lead generation on Pharmaceuticals sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 3 in our database
Found 33 in our records
HQ: Boulogne-billancourt, Ile-de-France, France
Ipsen
Ipsen is a global specialty-driven biopharmaceuticShow more...al company focused on innovation and specialty care.
HQ: Boulogne-billancourt, Ile-de-France, France
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 25, 2024
Founded Date: 1929
Number of Exits: 5
Company Type: For Profit
Stock Symbol: EPA:IPN
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@ipsen.com (100.0%)
-
Sandra Silvestri
EVP, Chief Medical Officer, Head of Global Medical Affairs, Patient Safety & Patient Affairs
s**************i@ipsen.com
-
Susan Tinney
s**********y@ipsen.com
-
Karen Hummel
Executive Director, National Health Systems, Medical Affairs
k**********l@ipsen.com
-
Helen Hsu
h*******u@ipsen.com
-
Unclassified inbox
Clinical.trials@ipsen.com
-
Unclassified inbox
corporate.communications@ipsen.com
-
Unclassified inbox
qualitycomplaints.russia.cis@ipsen.com
-
Unclassified inbox
ipsenepe@ipsen.com
-
Unclassified inbox
medical.information.russia.cis@ipsen.com
-
Unclassified inbox
medinfo.uk-ie@ipsen.com
-
Unclassified inbox
contact.web@ipsen.com
HQ: Osaka-shi, Osaka, Japan
Shionogi
Shionogi is a pharmaceutical company that offers pShow more...harmaceuticals, diagnostic reagents, and medical devices.
HQ: Osaka-shi, Osaka, Japan
Specialized In: Biotechnology, Medical Devices, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Feb 27, 2024
Founded Date: Mar 17, 1878
Number of Exits: 3
Company Type: For Profit
Stock Symbol: TYO:4507
Operating Status: Active
7 Emails
0 Phones
Main email format: ssmith@shionogi.com (100.0%)
-
Donald Pirkl
Supplier Manager
d****l@shionogi.com
-
Calvin Smith
Key Account Manager
c****h@shionogi.com
-
Fabio De Gregorio
f*********o@shionogi.com
-
Sol Yates
s****s@shionogi.com
-
Unclassified inbox
ShionogiCommunications@shionogi.com
-
General Inquiries
contact@shionogi.eu
-
General Inquiries
info@shionogi.co.jp
HQ: New York, New York, United States
Roivant Sciences
Roivant Sciences is a biopharmaceutical company foShow more...cused on the development of medicines and healthcare technologies to patients.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 25, 2024
Founded Date: May 2014
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:ROIV
Operating Status: Active
4 Emails
0 Phones
Main email format: sarah.smith@roivant.com (100.0%)
-
Matthew Gline
Chief Financial Officer
m***********e@roivant.com
-
Tanya Shaby
Partner, Legal
t*********y@roivant.com
-
Jamie Schiff
Software Engineer
j**********f@roivant.com
-
General Inquiries
info@roivant.com
- «
- 1
- »
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.